Syneos Health, Inc. (SYNH) Tops Q4 EPS by 13c, Offers FY19 Guidance

Syneos Health, Inc. (NASDAQ: SYNH) reported Q4 EPS of $0.95, $0.13 better than the analyst estimate of $0.82. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.15 billion.

GUIDANCE:

Syneos Health, Inc. sees FY2019 EPS of $3.03-$3.23, versus the consensus of $3.07. Syneos Health, Inc. sees FY2019 revenue of $4.62-4.73 billion, versus the consensus of $4.68 billion.

For earnings history and earnings-related data on Syneos Health, Inc. (SYNH) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Empire Petroleum posts $11.1M revenue in Q2 2026, narrows net loss